RANDOMIZED TRIAL OF LOW-DOSE VERSUS HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN THE INDUCTION TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER

被引:77
|
作者
CAVALLI, F
GOLDHIRSCH, A
JUNGI, F
MARTZ, G
MERMILLOD, B
ALBERTO, P
机构
[1] INSELSPITAL,INST MED ONCOL,CH-3010 BERN,SWITZERLAND
[2] INSELSPITAL,LUDWIG INST CANC RES,CH-3010 BERN,SWITZERLAND
[3] KANTONSSPITAL,MED KLIN C,DIV ONCOL,CH-9006 ST GALLEN,SWITZERLAND
[4] UNIV HOSP ZURICH,DIV ONCOL,CH-8091 ZURICH,SWITZERLAND
[5] HOP CANTONAL,SWISS GRP CLIN CANC RES,STAT OFF,CH-1211 GENEVA 4,SWITZERLAND
[6] HOP CANTONAL,DIV ONCOL,CH-1211 GENEVA 4,SWITZERLAND
关键词
D O I
10.1200/JCO.1984.2.5.414
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:414 / 419
页数:6
相关论文
共 50 条
  • [41] THE EFFECTS OF LOW AND HIGH-DOSE MEDROXYPROGESTERONE ACETATE ON SEX STEROIDS AND SEX-HORMONE BINDING GLOBULIN IN POSTMENOPAUSAL BREAST-CANCER PATIENTS
    DOWSETT, M
    LAL, A
    SMITH, IE
    JEFFCOATE, SL
    BRITISH JOURNAL OF CANCER, 1987, 55 (03) : 311 - 313
  • [42] CLINICAL-TRIAL OF HIGH-DOSE ORAL MEDROXYPROGESTERONE ACETATE IN THE TREATMENT OF METASTATIC BREAST-CANCER AND REVIEW OF THE LITERATURE
    DAVILA, E
    VOGEL, CL
    EAST, D
    CAIRNS, V
    HILSENBECK, S
    CANCER, 1988, 61 (11) : 2161 - 2167
  • [43] WEEKLY DOXORUBICIN WITH OR WITHOUT HIGH-DOSE A MEDROXYPROGESTERONE ACETATE IN HORMONE-RESISTANT ADVANCED BREAST-CANCER - A RANDOMIZED STUDY
    GUNDERSEN, S
    HANNISDAL, E
    LUNDGREN, S
    WIST, E
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (12) : 1775 - 1778
  • [44] LOW-DOSE AMINOGLUTETHIMIDE WITHOUT HYDROCORTISONE FOR THE TREATMENT OF ADVANCED POSTMENOPAUSAL BREAST-CANCER
    BRUNING, PF
    BONFRER, JMG
    HART, AAM
    VANDERLINDEN, E
    DEJONGBAKKER, M
    MOOLENAAR, AJ
    NOOIJEN, WJ
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (02): : 369 - 376
  • [45] HIGH-DOSE RETINIL ACETATE (RA) AND TAMOXIFEN (TAM) IN POSTMENOPAUSAL ADVANCED BREAST-CANCER PATIENTS (PTS)
    CANOBBIO, L
    REPETTO, L
    PASTORINO, G
    BREMA, F
    OLGIATI, A
    BOCCARDO, F
    BREAST CANCER RESEARCH AND TREATMENT, 1987, 10 (01) : 111 - 111
  • [46] RANDOMIZED TRIAL COMPARING AMINOGLUTETHIMIDE WITH HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN THERAPY FOR ADVANCED BREAST-CARCINOMA
    CANNEY, PA
    PRIESTMAN, TJ
    GRIFFITHS, T
    LATIEF, TN
    MOULD, JJ
    SPOONER, D
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (14) : 1147 - 1151
  • [47] HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN PATIENTS WITH ADVANCED PROSTATIC-CANCER
    SULMONI, M
    PFENNINGER, R
    MULLER, J
    BANDHAUER, K
    AKTUELLE UROLOGIE, 1993, 24 (06) : 334 - 337
  • [48] HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN BREAST-CANCER RESISTANT TO ENDOCRINE AND CYTOTOXIC THERAPY
    DELENA, M
    BRAMBILLA, C
    VALAGUSSA, P
    BONADONNA, G
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1979, 2 (03) : 175 - 180
  • [49] RANDOMIZED TRIAL OF LOW-DOSE ADRIAMYCIN AND CYCLOPHOSPHAMIDE +/- CALUSTERONE FOR ADVANCED BREAST-CANCER
    LLOYD, RE
    SALMON, SE
    JONES, SE
    JACKSON, RA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 126 - 126
  • [50] A RANDOMIZED COMPARATIVE TRIAL OF COMBINED VERSUS ALTERNATING THERAPY WITH CYTOSTATIC DRUGS AND HIGH-DOSE MEDROXYPROGESTERON ACETATE IN ADVANCED BREAST-CANCER
    WILS, JA
    BRON, H
    VANLANGE, L
    PANNEBAKKER, M
    ROMME, A
    SCHEERDER, H
    SMEETS, JB
    BEEX, LV
    CANCER, 1985, 56 (06) : 1325 - 1331